ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[청년의사] [ESMO 2023] 국산 CAR-T 치료제 ‘안발셀’ 허가 청신호?
2023/10/25
[ESMO 2023] 국산 CAR-T 치료제 ‘안발셀’ 허가 청신호? < 산업 < 뉴스 < 기사본문 – 청년의사 (docdocdoc.co.kr)
청년의사 김찬혁 기자
Prev
큐로셀, 2023 유럽종양학회에서 ‘최우수 포스터’ 선정
Next
큐로셀, 차세대 CAR-T 임상2상 완료 “국내 최초 사례”
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.